Abstract Submission for the 2024 RNATx Symposium IS NOW CLOSED
Abstract Submission IS CLOSED FOR RNATx 2024
Oral Submission Deadline: March 8, 2024
Poster Submission Deadline: March 22, 2024
Topics include:
- Structure and Function
- Mechanisms of RNA Pathways
- Oligonucleotide Drugs, Modifications, and Delivery
- mRNA Therapeutics
- Editing
- Translating Discoveries into the Clinic
- Initiatives in Education and DEI
All abstract submitters must acknowledge that they understand the talks and posters will be presented virtually and will be available to registered attendees on demand for up to 30 days following the meeting.
Abstracts received before the abstract deadline will be considered for poster presentations and/or a limited number of short talks. See abstract guidelines and helpful tips on how to increase your chances for a short talk.
All abstracts must be submitted on-line through the abstract submission system. Abstracts that are sent via e-mail or fax will not be included in the abstract assessment process by the Scientific Committee. Any abstracts submitted after the deadline will be eligible for poster presentations only. Please also note that we can only allow one abstract per presenting author. Abstracts will not be published and authors also reserve the right to publish their work elsewhere.
All abstracts will be reviewed by the organizers to ensure that the topic of the submission is consistent with the scope of the topics covered at the symposium. A small number of abstracts will be selected for short talks by the organizing committee.
Once the abstract is accepted, at least one of the authors must register for and present at the conference.
If you select "Yes" that you want to apply for an inclusivity grant and/or family support award, you must submit an application.
See Abstract Guidelines and Tips before submitting your abstract.